Subscribe To
Solar gets burned: enphase energy falls 25%
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy....
April 26, 2023, 9:23 pm
Erasca announces two poster presentations at the 2023 asco annual meeting
Posters will feature preliminary phase 1b combination data for potential best-in-class ERK1/2 inhibitor...
April 26, 2023, 9:00 pm
Why enphase energy has cratered after earnings
Growth is great, but that was already priced in....
April 26, 2023, 4:45 pm
Hookipa to present a trial in progress poster on its prostate cancer phase 1/2 clinical trial at asco
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class ...
April 26, 2023, 3:30 pm
Rain oncology: phase 3 milademetan data expected q2 of 2023
Rain Oncology: phase 3 Milademetan Data Expected Q2 Of 2023....
April 26, 2023, 2:34 pm
Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic...
April 26, 2023, 2:08 pm
Allogene therapeutics announces presentation of phase 1 data from the allo-501/501a trials in large b cell lymphoma at the american society of clinical oncology (asco) annual meeting
SOUTH SAN FRANCISCO, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pi...
April 26, 2023, 2:06 pm
Galera to present one-year reductions in cisplatin-related chronic kidney disease data from roman trial at 2023 american society of clinical oncology (asco) annual meeting
MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on deve...
April 26, 2023, 2:00 pm
Enphase stock drops 25% to lowest in nearly a year as company's weak guidance spooks wall street
Enphase Energy Inc. stock on Wednesday dropped to its lowest in nearly a year as investors worried that...
April 26, 2023, 1:44 pm
Enphase energy stock tanks after earnings: time to buy on the dip?
Enphase grew revenue and adjusted EPS by 65% and 73% year over year, respectively, to kick off 2023. Sp...
April 26, 2023, 1:31 pm
Rooftop solar: ain't no sunshine
Enphase Energy points out rising interest rates and new net metering rules in California are casting a ...
April 26, 2023, 1:17 pm
Enphase energy's (enph) q1 earnings beat, revenues rise y/y
Enphase Energy's (ENPH) first-quarter revenues of $726 million beat the Zacks Consensus Estimate by 0.4...
April 26, 2023, 12:54 pm
Zeb nickel kicks off further exploration drilling at flagship project in south africa
Zeb Nickel (TSX-V:ZBNI, OTC:ZBNIF) Corp revealed that it had kicked off further exploration drilling at its flagship Zeb Nickel (TSX-V:ZBNI, OTC:ZBNIF...
April 26, 2023, 11:44 am
60 degrees pharmaceuticals awarded u.s. patent covering tafenoquine for treatment of covid-19 and other lung infections
Patent provides exclusive use through 2040 of tafenoquine for treatment of COVID-19 and other lung infections. Tafenoquine is the active molecule in 6...
April 26, 2023, 11:34 am
Evelo biosciences provides clinical updates
– Topline Data from fourth cohort of EDP1815 phase 2 trial in atopic dermatitis did not meet primary ...
April 26, 2023, 11:30 am
Uvax bio announces publication of results from preclinical studies of hiv vaccine candidates
Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategies ...
April 26, 2023, 11:30 am
Novartis to present new data across oncology portfolio including kisqali phase iii natalee trial in early breast cancer at asco
Basel, April 26, 2023 — Novartis will present new data from its oncology portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual M...
April 26, 2023, 10:21 am
Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic...
April 26, 2023, 10:08 am
Usd/jpy: scope for further consolidation near term – uob
USD/JPY seems to have now moved into a consolidative phase and is likely to navigate within the 132.85-...
April 26, 2023, 9:29 am
Why is enphase energy (enph) stock down 19% today?
Enphase Energy (NASDAQ: ENPH ) stock is falling hard on Wednesday following the release of its earnings...
April 26, 2023, 9:28 am